Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for prevention of anthracycline-induced acute cardiotoxicity
IRCT20180506039554N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sildenafil in Cardiotoxicity, sponsored by Shiraz University of Medical Sciences. Started Aug 2017; status: completed.
02
Drugs
sildenafil
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on IRCT20180506039554N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180506039554N1.